Skip to content
  • Tuesday, 29 September 2026
  • 10:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • New Year, New Goggles: Resetting Your Lab Safety Game
Laboratory Safety & Compliance

New Year, New Goggles: Resetting Your Lab Safety Game

Layla Zulfa Sep 28, 2026 0

The Evolution of Laboratory Safety Standards Laboratory safety has evolved significantly over the past two decades. Historically, compliance was viewed…

Read More
Laboratory Safety & Compliance

New Year, New Goggles: Resetting Your Lab Safety Game

Layla Zulfa Sep 20, 2026 0

As clinical and research laboratories transition into 2026, the industry is grappling with a renewed emphasis on occupational safety that…

Read More
Laboratory Safety & Compliance

New Year, New Goggles: Resetting Your Lab Safety Game

Layla Zulfa Sep 13, 2026 0

As clinical and research laboratories transition into 2026, industry leaders are shifting their focus from stagnant, paper-based compliance toward dynamic,…

Read More
Pharmaceutical R&D

AI Transforms Pharmaceutical Regulatory Submissions: Predictive Intelligence and End-to-End Pipelines Emerge as Game-Changers

Teuku Ryan Jun 18, 2026 0

The pharmaceutical industry is undergoing a profound transformation driven by the rapid integration of Artificial Intelligence (AI), moving beyond early-stage…

Read More
How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance directorAbacus AI Emerges as a Comprehensive Solution Addressing AI Tool Sprawl and Enhancing Enterprise Workflow AutomationAustrian Researchers Unveil Groundbreaking Design to Merge Electron Microscopy with Quantum ComputingBorneo’s Cryptic Chorus: Unraveling the Mystery of Fanged Frogs and the Evolving Science of Species Discovery
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ